Creatvie Biolabs Released CreMap™ Epitope Mapping and Discovery Services
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Creatvie</strong> <strong>Biolabs</strong> <strong>Released</strong> CreMap <strong>Epitope</strong> <strong>Mapping</strong> <strong>and</strong> <strong>Discovery</strong> <strong>Services</strong><br />
Creative <strong>Biolabs</strong> is a biotech company specialized in early drug discovery <strong>and</strong><br />
development.<br />
With the common efforts of its scientists, Creative <strong>Biolabs</strong> successfully developed<br />
CreMap <strong>Epitope</strong> <strong>Mapping</strong> <strong>and</strong> <strong>Discovery</strong> <strong>Services</strong> based on its expert knowledge<br />
<strong>and</strong> rich research experience in this field.<br />
With the rapid development of immunology <strong>and</strong> bioinformatics, the techniques used<br />
in T cell <strong>and</strong> B cell epitope prediction <strong>and</strong> discovery have been greatly improved.<br />
However, problems of complicated experimental process, high economic cost, <strong>and</strong><br />
low resolution still remain unsolved. To help solve these problems, Creative <strong>Biolabs</strong>'<br />
academic group has developed the CreMap T cell (or B cell) epitope discovery<br />
platform based on the expert knowledge <strong>and</strong> rich research experience in this field.<br />
“We try our best to provide professional technical services to reduce the project cost,<br />
<strong>and</strong> at the same time improve the experimental accuracy,” Said Dr. Monika, scientific<br />
officer of Creative <strong>Biolabs</strong>.<br />
CreMap T cell epitope discovery platform is an advanced technology for the<br />
analysis of potential T cell epitopes. Compared with other strategies that require a<br />
significant investment of time <strong>and</strong> money, this platform provides an efficient <strong>and</strong> at<br />
the same time cost-effective solution which could be used for the mapping of both<br />
CD4 + <strong>and</strong> CD8 + T cell epitopes in the field of protein drug development or peptide<br />
vaccine design.<br />
In addition, Creative <strong>Biolabs</strong> has also developed an advanced B cell epitope mapping<br />
platform, in which both conformational <strong>and</strong> linear epitopes could be effectively<br />
mapped in high-throughput <strong>and</strong> low cost.<br />
About Creative <strong>Biolabs</strong><br />
Creative <strong>Biolabs</strong> is specialized in providing custom biotechnology <strong>and</strong><br />
pharmaceutical services that cover the full scope of biotechnology needs of early<br />
antibody discovery <strong>and</strong> development. As a trusted provider of the most cost-effective<br />
outsourcing solutions, Creative <strong>Biolabs</strong> has been working for a large number of<br />
satisfied clients from biotechnology <strong>and</strong> pharmaceutical companies as well as<br />
government <strong>and</strong> academic research laboratories all over the world.<br />
http://www.abnewswire.com/adminpreview.php?id=r7moGxk